Feedback / Questions
Venclexta (venetoclax) - Roche, AbbVie
prexigebersen (BP1001) - Bio-Path
decitabine/ tetrahydrouridine (EPI01) - EpiDestiny, Novo Nordisk
https://www.marketwatch.com/press-release/10-k-bio-path-holdings-inc-2021-03-09?siteid=bigcharts&dist=bigcharts&tesla=y
Mar 9, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next